NFA
RIGL icon

Nationwide Fund Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Nationwide Fund Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-23,692
Closed -$602K – 1653
2017
Q3 		$602K Sell
23,692
-1,074
-4% -$26.1K ﹤0.01% 2086
2017
Q2 		$676K Buy
24,766
+4,136
+20% +$113K ﹤0.01% 2017
2017
Q1 		$683K Sell
20,630
-12,198
-37% -$311K ﹤0.01% 1985
2016
Q4 		$781K Sell
32,828
-790
-2% -$22.6K ﹤0.01% 1918
2016
Q3 		$1.23M Buy
33,618
+4,630
+16% +$133K 0.01% 1644
2016
Q2 		$646K Buy
28,988
+13,090
+82% +$325K ﹤0.01% 2003
2016
Q1 		$331K Hold
15,898
– – ﹤0.01% 2296
2015
Q4 		$482K Buy
15,898
+10,098
+174% +$306K ﹤0.01% 2134
2015
Q3 		$143K Sell
5,800
-17,888
-76% -$534K ﹤0.01% 2736
2015
Q2 		$760K Sell
23,688
-503
-2% -$19.2K ﹤0.01% 2023
2015
Q1 		$864K Buy
24,191
+7,912
+49% +$217K ﹤0.01% 1959
2014
Q4 		$370K Buy
16,279
+927
+6% +$18.7K ﹤0.01% 2352
2014
Q3 		$298K Hold
15,352
– – ﹤0.01% 2502
2014
Q2 		$557K Buy
15,352
+8,656
+129% +$294K ﹤0.01% 2203
2014
Q1 		$260K Sell
6,696
-115
-2% -$4.1K ﹤0.01% 2369
2013
Q4 		$194K Sell
6,811
-114
-2% -$3.35K ﹤0.01% 2700
2013
Q3 		$248K Sell
6,925
-5,024
-42% -$183K ﹤0.01% 2558
2013
Q2 		$399K Buy
+11,949
New +$541K ﹤0.01% 2123

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nationwide Fund Advisors's RIGL Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Rigel Pharmaceuticals (RIGL) in Q4 2017, closing a stake of 23,692 shares — an estimated $602K sold.

Nationwide Fund Advisors first reported a position in RIGL in Q2 2013 and held it in 18 quarters. The position peaked at $1.23M in Q3 2016. 121 funds tracked by Wall St. Rank hold RIGL as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Rigel Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 23,692 Rigel Pharmaceuticals shares in Q4 2017, an estimated $602K.
  • Nationwide Fund Advisors first reported a position in Rigel Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Rigel Pharmaceuticals position peaked at $1.23M in Q3 2016.
  • 121 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.